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The SWEDEHEART Example*Thomas M. Maddox, MD, MSC,y T. Bruce Ferguson, JR, MDzT he link between type 1 diabetes mellitus(T1DM) and cardiovascular disease is strong.Multiple studies have demonstrated that
T1DM results in atherosclerosis and inﬂammation
and confers signiﬁcant risk for cardiac events and
that these risks are directly related to glycemic con-
trol, as measured by glycosylated hemoglobin
(HbA1c) levels (1–4). Accordingly, the American Dia-
betes Association clinical guidelines call for tight gly-
cemic control among these patients to minimize
cardiovascular morbidity and mortality (5).SEE PAGE 535The current study by Nyström et al. (6) supports
this admonition. Using observational data from
Swedish patients, the investigators examined out-
comes among patients with T1DM who were under-
going coronary artery bypass graft (CABG) procedures
between 1997 and 2012. These investigators found
that patients with progressively higher preope-
rative HbA1c values had worse cardiac outcomes
compared with patients with normal glycemic
levels. The methods were rigorous, and the ﬁndings
were convincing. These insights will provide useful*Editorials published in the Journal of the American College of Cardiology
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Several studies have examined the effect of dia-
betes and preoperative diabetic control on outcomes
after CABG, so what does this study add to the pub-
lished data? We believe that it has 2 important con-
tributions. First, this study investigates the incidence
of long-term adverse events in T1DM after CABG.
Second, this study illustrates the potential of health
data to fuel both clinical practice and research in an
iterative fashion. This approach—a fundamental tenet
of “learning health care systems”—can overcome the
historical divide between practice and research, fuel
quicker translation of research insights into clinical
practice, and bring front-line clinical insights into the
conduct of clinical research (7).
The study by Nyström et al. (6) used data from
the SWEDEHEART system (Swedish Web-system for
Enhancement and Development of Evidence-based
care in Heart disease Evaluated According to Rec-
ommended Therapies) (8). Established in 2009, the
national Web-based clinical registry collects data on
patients with coronary artery disease. It merged
existing registries of coronary care units, coronary
angiography and interventions, cardiac surgical
procedures, and cardiac secondary prevention into a
cohesive, longitudinal registry for patients hospi-
talized with acute coronary syndrome or undergo-
ing coronary or valvular intervention. Importantly,
this was facilitated by the unique personal identity
number assigned to every Swedish citizen. The
SWEDEHEART data are also combined with national
databases of vital status, hospitalizations, and
pharmacy data, thus allowing for a comprehen-
sive view of patient care and outcomes. A central
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545coordinating center provides data and quality
oversight.
SWEDEHEART advances care improvements in
coronary artery disease by informing both practice
and research. Participating caregivers receive inter-
active process and outcomes data reports for their
patients. These data are also used for intrahospital
and interhospital comparisons, for public reporting,
to identify areas for quality improvement, and to
monitor the impact of improvement projects over
time. SWEDEHEART also makes these same data
available for research; this study by Nyström et al.
is but one example. SWEDEHEART also serves as
an infrastructure for pragmatic randomized con-
trolled trials. As demonstrated by the recent TASTE
(Thrombus Aspiration in ST-Elevation in Myocardial
Infarction in Scandinavia) trial (9), the registry iden-
tiﬁed potential enrollees for the trial and collected
endpoints and other data during the trial. These
measures dramatically improved the trial’s efﬁciency
and reduced its costs.
For practitioners in the United States, the
SWEDEHEART registry also exempliﬁes many of the
“learning health care system” concepts codiﬁed in the
Institute of Medicine report, Best Care at Lower Cost
(7). Improvements in digital infrastructure to capture
clinical data more accurately to inform practice and
evidence, accelerated incorporation of the best clin-
ical knowledge into care decisions by cross-platform
data integration, improvements in care coordination
and communication across different care settings,
and an increase in transparency of health system
performance are all aspects of the SWEDEHEART
registry approach.
Do efforts currently exist in the United States to
develop a similar system? In the cardiovascular
domain, the Society of Thoracic Surgeons National
Database and the American College of Cardiology’s
National Cardiovascular Data Registry (NCDR) pro-
grams both host hospital-based cardiac clinical regis-
tries that provide valuable performance and
benchmarking information for quality improvement
and public reporting (10). Similarly, the Veterans
Affairs (VA) Clinical Assessment, Reporting, and
Tracking (CART) program uses software integrated
into the VA’s electronic health record (EHR) to
collect information on all its coronary interventionprocedures and uses the data for quality improvement
and research activities (11). Other efforts exist outside
the cardiovascular realm. Large, national registries,
such as the Health Maintenance Organization
Research Network (HMORN), the National Patient-
Centered Clinical Research Network (PCORnet), and
the Food and Drug Administration’s Mini-Sentinel
program use EHR-based data from participating
health systems to conduct clinical research, pragmatic
trials, and safety monitoring programs (12). Various
commercial efforts also collect clinical data for quality
improvement, clinical research, and cost reduction.
Ideally, these registries would fuel a cohesive data
stream of clinical, quality, operational, administra-
tive, and cost data to facilitate care quality and clinical
research (13). Unfortunately, they are not currently
designed to deliver this infrastructure. For example,
most of the registries are not yet integrated into the
clinical workﬂows of EHR systems and capture only a
subset of patients over a limited time frame. In addi-
tion, cross-platform registry integration for clinical
research is hampered by registry infrastructure limi-
tations and the lack of a unique patient identiﬁer in
the United States. Finally, much additional work is
needed to establish a supportive leadership and reg-
ulatory environment for learning health care systems.
The study by Nyström et al. uniquely documents
the importance of preoperative glycemic control
before CABG in patients with T1DM. However, its
larger importance is in drawing our attention to the
very real potential for learning health care systems
here in the United States. This Swedish study pro-
vides a promising example of the power of the ability
of learning health care systems to generate new in-
sights, to translate these insights into quality
improvement programs for certain populations, and
to trigger new research to investigate optimal treat-
ment strategies and targets. U.S. learning health care
system initiatives modeled on SWEDEHEART could
fuel a “virtuous cycle” of care improvement and
research in cardiovascular disease.
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